Chairman, President and CEO of Horizon Therapeutics Plc (30-Year Financial, Insider Trades) Timothy P Walbert (insider trades) sold 11,323 shares of HZNP on 01/22/2021 at an average price of $76.47 a share. The total sale was $865,870.
Horizon Pharma PLC is a pharmaceutical company. The company focuses on researching, developing and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases. Horizon Therapeutics PLC has a market cap of $17.16 billion; its shares were traded at around $77.730000 with a P/E ratio of 21.23 and P/S ratio of 9.21. GuruFocus has detected 2 severe warning signs with Horizon Therapeutics PLC. .
CEO Recent Trades:
- Chairman, President and CEO Timothy P Walbert sold 11,323 shares of HZNP stock on 01/22/2021 at the average price of $76.47. The price of the stock has increased by 1.65% since.
- Chairman, President and CEO Timothy P Walbert sold 211,204 shares of HZNP stock on 01/15/2021 at the average price of $77.89. The price of the stock has decreased by 0.21% since.
Directors and Officers Recent Trades:
- EVP & President, International Vikram Karnani sold 2,731 shares of HZNP stock on 01/22/2021 at the average price of $76.81. The price of the stock has increased by 1.2% since.
- EVP, Chief Human Resources Off Irina Konstantinovsky sold 2,226 shares of HZNP stock on 01/22/2021 at the average price of $76.81. The price of the stock has increased by 1.2% since.
- EVP, Chief Human Resources Off Irina Konstantinovsky sold 26,844 shares of HZNP stock on 01/06/2021 at the average price of $74.76. The price of the stock has increased by 3.97% since.
- EVP, Technical Operations Michael A. Desjardin sold 27,106 shares of HZNP stock on 01/06/2021 at the average price of $75. The price of the stock has increased by 3.64% since.
- EVP & President, International Vikram Karnani sold 30,031 shares of HZNP stock on 01/06/2021 at the average price of $75. The price of the stock has increased by 3.64% since.
For the complete insider trading history of HZNP, click here
.
